6796 — Medimaging Integrated Solution Income Statement
0.000.00%
- TWD3.37bn
- TWD3.24bn
- TWD537.15m
- 52
- 15
- 21
- 16
Annual income statement for Medimaging Integrated Solution, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 315 | 402 | 486 | 502 | 537 |
Cost of Revenue | |||||
Gross Profit | 175 | 219 | 256 | 254 | 308 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 309 | 338 | 399 | 442 | 445 |
Operating Profit | 5.7 | 64.8 | 86.6 | 59.6 | 91.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.04 | 60.2 | 80.9 | 87.4 | 93 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.78 | 54.1 | 66.5 | 70 | 74.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.78 | 54.1 | 66.5 | 70 | 74.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.78 | 54.1 | 66.5 | 70 | 74.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.162 | 1.81 | 2.24 | 2.14 | 2.18 |
Dividends per Share |